On September 28, 2021, Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. closed the transaction. Pan-China Certified Public Accountants issued a capital verification report that the Company has received total proceeds of CNY 601,599,986.90 by issuing 37,181,705 shares at the price of CNY 16.18 per share. The transaction included group of individual investors including Caitong Fund Management Co., Ltd. which acquired 5,352,303 shares for CNY 86,600,262.54, Zhuhai Jinteng Equity Investment Fund Partnership Enterprise (Limited Partnership) a fund managed by Shanghai Ivy Investment Holdings Co., Ltd. which acquired 3,708,281 shares for CNY 59,999,986.58, and Yingshui Investment Co., Ltd.-Yingshui Taishun No.

1 Private Securities Investment Fund acquired 3,090,234 shares for CNY 49,999,986.12. The share capital will increase from 156,529,800 shares to 193,711,505 shares. The issuance fees were CNY 4,252,830.12 and net proceeds were CNY 597,347,156.78.